Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Wascher Thomas |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Kaser, S; Sourij, H; Clodi, M; Aziz, F; Fasching, P; Fritsch, M; Kojzar, H; Ludvik, B; Mader, J; Resl, M; Rega-Kaun, G; Ress, C; Sourij, C; Stechemesser, L; Stingl, H; Tripolt, N; Wascher, T
Characteristics of people with type 2 diabetes in Austrian primary care - data from the AUSTRO-PROFIT study
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(Suppl7):S781-S782.-51. Jahrestagung der ÖDG; NOV 16-18, 2023; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
Sourij, H; Clodi, M; Aziz, F; Fasching, P; Fritsch, M; Kojzar, H; Ludvik, B; Mader, J; Resl, M; Rega-Kaun, G; Ress, C; Sourij, C; Stechemesser, L; Stingl, H; Wascher, T; Kaser, S
Prevalence of undiagnosed glucose metabolism disorders during preventive examinations - data from the AUSTRO-PROFIT study
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(Suppl7):S782-S782.-51. Jahrestagung der ÖDG; NOV 16-18, 2023; Salzburg, AUSTRIA.
[Poster]
Web of Science
Tripolt, N; Eder, M; Wascher, T; Sourij, H
A comparison between insulin aspart and two biphasic insulin asparts during two consecutive meals in patients with type 2 diabetes
The Central European Journal of Medicine. 2013; 257-257.-44. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 26-28, 2013; Salzburg, AUSTRIA.
[Poster]
Tripolt, N; Eder, M; Wascher, T; Sourij, H;
A comparison between insulin aspart and two biphasic insulin asparts during two consecutive meals in patients with type 2 diabetes.
WIEN KLIN WOCHENSCHR. 2013; 125(17-18):557-557.
[Poster]
Web of Science
Tripolt, N; Narath, S; Eder, M; Pieber, T; Wascher, T; Sourij, H
Multifactorial risk factor intervention in patients with type 2 diabetes significantly reduces carotid intima-media thickness
The Central European Journal of Medicine. 2013; 556-556.-44. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 26-28, 2013; Salzburg, AUSTRIA.
[Poster]
Tripolt, N; Narath, S; Eder, M; Pieber, T; Wascher, T; Sourij, H;
Multifactorial risk factor intervention in patients with type 2 diabetes significantly reduces carotid intima-media thickness.
WIEN KLIN WOCHENSCHR. 2013; 125(17-18):556-556.
[Oral Communication]
Web of Science
Tripolt, NJ; Eder, M; Wascher, T; Sourij, H
A comparison between insulin aspart and two biphasic insulin asparts regarding glucose and lipid metabolism during two consecutive meals in patients with type 2 diabetes
Supplement 02/13 Wiener Klinische Wochenschrift. 2013; S6--41. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 21-23, 2013; Salzburg, AUSTRIA.
[Poster]
FullText
Tripolt, NJ; Narath, SH; Eder, M; Pieber, T; Wascher, T; Sourij, H
Cardiovascular risk factor treatment in patients with type 2 diabetes significantly reduces carotid intima-media thickness
Supplement 02/13 Wiener Klinische Wochenschrift. 2013; S7--41. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 21-23, 2013; Salzburg, AUSTRIA.
[Oral Communication]
FullText
Tripolt, NJ; Narath, SH; Eder, M; Pieber,T; Wascher, T; Sourij, H
Effect of multiple risk factori intervention on carotid atherosclerosis in patients with type 2 diabetes
Proceedings of International Congress on Coronary Artery Disease 2013. 2013; -ICCAD - International Congress on Coronary Artery Disease ; OCT 13 - 16, 2013; Florence, ITALY.
[Poster]
Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; Marz, W; Wascher, TC; Trauner, M
LOW-DOSE ATORVASTATIN IMPROVES DYSLIPIDEMIA AND VASCULAR FUNCTION IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS AFTER ONE YEAR OF TREATMENT.
J HEPATOL. 2010; 52: S431-S432.-45th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 14-18, 2010; Vienna, AUSTRIA.
Doi: 10.1016/S0168-8278(10)61118-X
[Poster]
Web of Science
FullText
FullText_MUG
Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M
Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.
3rd Annual Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry; OCT 27-30, 2010; Salzburg, AUSTRIA. 2010.
[Oral Communication]
Tripolt, N; Meinitzer, A; Eder, M; Wascher, T; Pieber, TR; Sourij, H
Multifactorial Risk Factor Intervention in Type 2 Diabetes significantly improves Global Arginine Bioavailability Ratio
WIEN KLIN WOCHENSCHR. 2010; 122: S22-S22.
[Poster]
Web of Science
Tripolt, NJ; Meinitzer, A; Eder, M; Graninger, WB; Pieber, TR; Wascher, T; Sourij, H
Multifactorial risk factor intervention in type 2 diabetic patients significantly improves global arginine bioavailability ratio
DIABETOLOGIA. 2010; 53: 1337
[Poster]
Web of Science
Tripolt, NJ; Meinitzer, A; Eder, M; Wascher, TC; Pieber, TR; Sourij, H
Multifactorial risk intervention in type 2 diabetic patients significantly improves global arginine bioavailability ratio
Abstract book2010; -Joint ZMF & doctoral days; 5./6. November 2010; Graz.
[Poster]
Tripolt, NJ; Meinitzer, A; Eder, M; Wascher, TC; Pieber, TR; Sourij, H
Multifaktorielle Risikofaktorintervention bei Typ-2-Diabetikern verbessert signifikant die Global Arginin Bioavailability Ratio
Austrian Journal of Endocrinology and Metabolism2010; Sonderheft 1: 20-20.-15. Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel; 7.-8.Mai 2010; Wien. (ISBN: 1998-7773 )
[Poster]
Sourij, H; Saely, C; Jahnel, H; Zweiker, R; Hoefle, G; Wascher, T; Drexel, H
IMPAIRED GLUCOSE TOLERANCE STRONGLY AND SIGNIFICANTLY INCREASES THE RISK OF FUTURE VASCULAR EVENTS AMONG ANGIOGRAPHIED CORONARY PATIENTS
ATHEROSCLER SUPPL. 2009; 10(2):
[Oral Communication]
Web of Science
Sourij, H; Saely, CH; Jahnel, H; Zweiker, R; Marte, T; Schmid, F; Hoefle, G; Wascher, TC; Drexel, H
Impaired glucose tolerance strongly and significantly increases the risk of future vascular events among angiographied coronary patients
EUR J CLIN INVEST. 2009; 39: 44-44.
[Oral Communication]
Web of Science
Sourij, H; Wascher, T; Lindeman, J; Kooistra, T; Pacini, G; Roden, M
Longterm Treatment with infliximab did not affect insulin resistance and Endothelial function in men with Metabolic Syndrome - a Pilot study.
WIEN KLIN WOCHENSCHR. 2009; 121: S26-S26.-Jahrestagung der Österreichischen Diabetesgesellschaft; NOV 19-21, 2009; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M
Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.
39. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 26-28, 2009; Maikammer, GERMANY. 2009.
[Oral Communication]
Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M
Improvement of lipoprotein pattern and vascular function in patients with primary biliary cirrhosis after long-term treatment with atorvastatin.
1st Styrian Conference on Lipid Mass Spectrometry; OCT 21-22, 2009; Graz, AUSTRIA. 2009.
[Poster]
Stojakovic, T; de Campo, A; Scharnagl, H; Sourij, H; Schmölzer, I; Wascher, TC; März W
Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients with type 2 diabetes and/or coronary heart disease.
Clin Chem Lab Med 2009; 47(9):A47-A47.-6th Annual Conference of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL); OCT 7-10, 2009; Leipzig, GERMANY.
[Poster]
Stojakovic, T; de Campo, A; Scharnagl, H; Sourij, I; Schmolzer, I; Wascher, TC; Marz, W
Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients at high risk of coronary events
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A20-A20.-40. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 17-19, 2009; Vienna, AUSTRIA.
[Poster]
Web of Science
Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, M; Wagner, M; Sourij, H; Stauber, RE; Marz, W; Wascher, TC; Trauner, M
Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A26-A26.-40.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 17-19, 2009; Vienna, AUSTRIA.
[Poster]
Web of Science
Winklhofer-Roob, BM; Faustmann, G; Fuchs, S; Meinitzer, A; Ottl, K; Khoschsorur, G; Greilberger, J; Tiran, B; Fasching, U; Sourij, H; Wascher, T; Roob, JM
Oxidant-antioxidant imbalance in patients with nephropathy associated with type 2 diabetes: Case-control study of the PREDICTIONS project
FREE RADICAL RES. 2009; 43: 49-49.-SFRR-Europe Meeting 2009; Aug 26-29, 2009; Rome, ITALY.
[Oral Communication]
Web of Science
Saely, CH; Drexel, H; Sourij, H; Aczel, S; Jahnel, H; Zweiker, R; Langer, P; Mare, T; Hoefle, G; Benzer, W; Wascher, TC
Key role of postchallenge hyperglycemia for the presence and extent of coronary atherosclerosis: An angiographic study
J AMER COLL CARDIOL. 2008; 51(10):A228-A228.
[Oral Communication]
Web of Science
Scharnagl, H; Stojakovic, T; De Campo, A; Wascher, T; März, W
The effect of fluvastatin and ezetimib on dense low density lipoproteins in patients with hypercholesterolemia and CHD.
15. Jahrestagung der Austrian Atherosclerosis Society (AAS). ; APR 18-19, 2008; St.Gilgen, AUSTRIA. 2008.
[Poster]
Stojakovic, T; de Campo, A; Scharnagl, H; Sourij, H; Schmölzer, I; Wascher, TC; März W
Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients at high risk of coronary events.
38. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 27-29, 2008; Maikammer, Deutschland. 2008.
[Oral Communication]
Stojakovic, T; de Campo, A; Scharnagl, H; Sourij, H; Schmölzer, I; Wascher, TC; März W
Effekte von Fluvastatin-Monotherapie oder in Kombination mit Ezetimibe auf LDL-Subfraktionen in einem Hochrisikokollektiv.
Wien Klin Wochenschr 2008; 120/19-20: S22-S22.-36. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 20-22, 2008; Baden, AUSTRIA.
[Oral Communication]
Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; März, W; Wascher, TC; Trauner, M
Improvement of dyslipidemia and vascular function in patients with primary biliary cirrhosis after long-term treatment with atorvastatin.
Clin Chem Lab Med. 2008; 46(9):A181-A181.-5. Jahrestagung der Deutschen Vereinten Gesellschaft für Klinische Chemie und Laboratoriumsmedizin (DGKL); SEP 21-24, 2008; Mannheim, GERMANY.
[Poster]
Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Wagner, M; Sourij, H; März, W; Wascher, TC; Trauner, M
Long-term treatment with atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis.
15. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); APR 18-19, 2008; St. Gilgen, AUSTRIA. 2008.
[Poster]
Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Wagner, M; Sourij, H; März, W; Wascher, TC; Trauner, M
Long-term treatment with atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis.
Z Gastroenterol. 2008; 45: 1-1.-41. Jahrestagung und 19. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); MAI 29-31, 2008; Millstatt, AUSTRIA.
[Oral Communication]
Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Wagner, M; Wascher, TC; März, W; Trauner, M.
Improvement of dyslipidemia and vascular function in patients with cholestatic liver disease after long-term treatment with atorvastatin
Hämostaseologie. 2008; 28(1-2):A62-A62.-52. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung e. V. (GTH); FEB 20-23, 2008; Wiesbaden, Germany.
[Poster]
Stojakovic, T; Putz-Bankuti, C; Wagner, M; Scharnagl, H; Wascher, TC; Marz, W; Trauner, M
Long-term treatment with atorvastatin in patients with cholestatic liver disease.
ATHEROSCLER SUPPL 2008; 9(1):197-197.-77th Congress of the European Atherosclerosis Society; APR 26-29, 2008; Istanbul, TURKEY.
[Poster]
Aichner, FT; Topakian, R; Alberts, MJ; Bhatt, DL; Haring, HP; Hill, MD; Montalescot, G; Goto, S; Wascher, TC; Mas, JL; Steg, PG; Rother, J
Baseline data and 1-year outcomes for patients with asymptomatic carotid stenosis: Results of the reduction of atherothrombosis for continued health registry
STROKE. 2007; 38(2):573-573.
[Poster]
Web of Science
DeCampo, A; Schmoelzer, I; Kettler-Schmut, E; Sourij, H; Forst, I; Wascher, IC
Non-glycaemic effects of insulin-therapy: a comparison between insulin aspart and normal insulin during two consecutive meals in patients with type 2 diabetes
DIABETOLOGIA. 2007; 50: S412-S413.-Annual Meeting of the EASD; SEP 17-21, 2007; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
Kruschitz, R; Lothaller, H; Wascher, TC; Liebmann, PM; Schnedl, W; Wallner, SJ
Evaluation of Weight-Management Programs and the impact of the return ratio of questioning
Aktuelle Ernährungsmedizin. 2007; 3: 137--6. Dreiländertagung der AKE, DGEM und GESKES; MAI 31- JUN 2; Innsbruck, Austria.
[Poster]
Perl, S; Schmölzer, I; Sourij, H; Pressl,H; Eder, M; Wascher, TC; Zweiker, R
Metabolische und vaskuläre Effekte der Angiotensin-I-Rezeptor Blocker bei Hypertonikern: Ein Vergleich von Losartan und Telmisartan.
Jahrestagung der Österreichischen Kardiologischen Gesellschaft; MAY 31 - JUNE 2, 2007; Salzburg, AUSTRIA. 2007.
[Poster]
Riedmueller, G; Wascher, TC; Brueck, CC; Gerdova, J; Breuss, B; Obermayer-Pietsch, B; Fahrleitner-Pammer, A; Dobnig, H
PTH - a new cardiovascular risk factor?
EXP CLIN ENDOCRINOL DIABETES. ; 115: S87-S88.
[Poster]
Web of Science
Saely, CH; Drexel, H; Sourij, H; Aczel, S; Jahnel, H; Zweiker, R; Langer, P; Zweiker, R; Marte, T; Hoefle, G; Benzer, W; Wascher, TC
The association of postprandial and fasting hyperglycaemia with angiographically determined coronary artery disease: a cross-sectional study
EUR J CLIN INVEST. 2007; 37: 68-68.-41st Annual Scientific Meeting of the European Society for Clinical Investigation ; APR 17-20, 2007; Uppsala, Sweden.
[Poster]
Web of Science
Saely, CH; Drexel, H; Sourij, H; Aczel, S; Jahnel, H; Zweiker, R; Langner, P; Marte, T; Hoefle, G; Benzer, W; Wascher, TC
Postprandial hyperglycemia is a key determinant of coronary atherosclerosis: an angiographic study.
Diabetes Vasc Dis Res; Supplementum 4: S52-S53.-2nd International Congress on Prediabetes and the Metabolic Syndrome; MAR 25-28, 2007; Barcelona, SPAIN.
[Poster]
Schmoelzer, I; Kettler-Schmutt, E; Pressl, H; Sourij, H; Wascher, TC
Efficacy and safety of continous, intravenous glucagon-like-peptide 1 (GLP-1) in comparison to insulin infusion for normalisation of hyperglycaemia in patients with type 2 diabetes
DIABETOLOGIA. 2007; 50: S351-S351.-Annual Meeting of the EASD; SEP 17-21, 2007; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
Schmölzer, I; Schmut, E; de Campo, A; Sourij, H; Stojakovic, T; Scharnagl, H; Forst, T; Wascher, TC
Nicht-glykämische Effekte der Insulintherapie: Ein Vergleich von Insulin Aspart und Normalinsulin während zwei aufeinanderfolgender Mahlzeiten bei Patienten mit Typ-II-Diabetes.
Abstracts zur 35. Jahrestagung der Österreichischen Diabetesgesellschaft2007; 119(S4):23-23.-Jahrestagung der Österreichischen Diabetesgesellschaft; NOV 29 - DEC 01, 2007; Innsbruck, AUSTRIA.
[Poster]
Schmölzer, I; Schmut, E; Eder, M; Pressl, H; Sourij, H; Wascher,TC
Effektivität und Sicherheit von kontinuierlichem, intravenösem Glucagon-Like-Peptide-1 im Vergleich mit einer strukturierten Insulininfusion zum Erreichen der Normoglykämie bei Typ-2 Diabetikern.
Abstracts, 35. Jahrestagung der Österreichischen Diabetesgesellschaft2007; 119(S4):22-22.-Jahrestagung der Österreichischen Diabetesgesellschaft; NOV 29 - DEC 01, 2007; Innsbruck, AUSTRIA.
[Oral Communication]
Sourij, H; Dittrich, P; Paulweber, B; Iglseder, B; Wascher, TC
Insulinresistenz als Risikofaktor für Carotisatherosklerose: Ein Vergleich des HOMA-Modells mit dem Short Insulin Tolerance Test
J Ernährungsmedizin2007; (3):26-26.-Jahrestagung der Österreichischen Adipositasgesellschaft; OCT 19-21, 2007; Seggau, AUSTRIA.
[Oral Communication]
Sourij, H; Saely, CH; Aczel, S; Jahnel, H; Zweiker, R; Langer, P; Marte, T; Hoefle, G; Benzer, W; Wascher, TC; Drexel, H
Gestörte Glukosetoleranz erhöht signifikant das Risiko für vaskuläre Ereignisse bei angiographierten Koronarpatienten.
Abstracts zur 35. Jahrestagung der Österreichischen Diabetesgesellschaft2007; 119(S4):24-24.-Jahrestagung der Österreichischen Diabetesgesellschaft; NOV 29 - DEC 01, 2007; Innsbruck, AUSTRIA.
[Oral Communication]
Sourij, H; Schmölzer, I; Dittrich, P; Paulweber, B; Iglseder, B; Wascher, TC
Insulinresistenz als Risikofaktor für Carotisatherosklerose: ein Vergleich des HOMA-Modells mit dem short insulin tolerance test.
Abstracts zur 35. Jahrestagung der Österreichischen Diabetesgesellschaft2007; 119(S4):24-24.-Jahrestagung der Österreichischen Diabetesgesellschaft; NOV 29 - DEC 01, 2007; Innsbruck, AUSTRIA.
[Poster]
Sourij, H; Schmölzer, I; Dittrich, P; Paulweber, B; Iglseder, B; Wascher TC
Insulin resistance as a risk factor for carotid atherosclerosis: a comparison of the HOMA-model and the short insulin tolerance test.
Diabetes Vasc Dis Res; Supplementum 4: S28-S29.-2nd International Congress on Prediabetes and the Metabolic Syndrome; MAR 25-28, 2007; Barcelona, SPAIN.
[Oral Communication]
Wascher, TC; Renner, W; Sourij, H; Schmölzer, I; Winkelmann, BR; Boehm, BO; Maerz, W;
Der glukometabolische Phänotyp, nicht aber die Insulinresistenz sind prädiktiv für das Ausmaß der koronaren Herzkrankheit und die Mortalität bei koronarangiographierten Patienten. Eine Analyse der LURIC Population.
Abstracts zur 35. Jahrestagung der Österreichischen Diabetesgesellschaft2007; 119(S4):28-28.-Jahrestagung der Österreichischen Diabetesgesellschaft; NOV 29 - DEC 01, 2007; Innsbruck, AUSTRIA.
[Poster]
Weitgasser, R; Pfutzner, A; Kerschgens, B; Drexel, H; Prager, R; Ludvik, B; Wascher, T; Hoppichler, E; Berger, S; Forst, T; Grafinger, P
Impact of cinnamon vs. placebo on surrogate markers of metabolic control in patients with type 2 diabetes mellitus
DIABETOLOGIA. 2007; 50: S378-S379.
[Poster]
Web of Science
Säly, CH; Sourij, H; Aczel, S; Jahnel, H; Langer, P; Zweiker, R; Marte, T; Höfle, G; Benzer, W; Drexel, H; Wascher, TC
Assoziation zwischen Glukosetoleranz und angiographisch nachgewiesener koronarer Herzkrankheit.
19(S4):16-16.-Jahrestagung der Österreichischen Diabetesgesellschaft; NOV 16-18, 2006; Innsbruck, AUSTRIA. , 19
[Poster]
Schmölzer, I; Schmut, E; de Campo, A; Sourij, H; Wascher, T
Stabilerer Glukoseverlauf über zwei aufeinanderfolgende Mahlzeiten bei Typ 2 Diabetikern unter Novorapid.
Diabetologie und Stoffwechsel. 1: S82-S82.-Jahrestagung der Deutschen Diabetesgesellschaft 2006; MAY 24-27, 2006; Leipzig, Germany.
[Poster]
Sourij, H; Jahnel, H; Zweiker, R; Eder, M; Wascher, TC
Wie häufig erreichen Diabetiker mit KHK die vorgegebenen Therapieziele?
Diabetologie und Stoffwechsel. 1: S100-S100.-Jahrestagung der Deutschen Diabetesgesellschaft 2006; MAY 24-27, 2006; Leipzig, Germany.
[Poster]
Sourij, H; Strunk, D; Rohde, E; Wascher, TC
Das Wachstum zirkulierender endothelialer Vorläuferzellen von Typ II Diabetikern ist mit der Art der Diabetestherapie assoziert.
Wiener Klinische Wochenschrift. 19(S4):19-20.-Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 16-18, 2006; Innsbruck, AUSTRIA.
[Oral Communication]
Sourij, H; Zweiker, R; Wascher, TC
Effekte von Pioglitazon auf die Endothelfunktion und Insulinsensitivität bei Patienten mit KHK und neu diagnostiziertem Diabetes mellitus Typ II.
Diabetologie und Stoffwechsel. 1: S99-S99.-Jahrestagung der Deutschen Diabetesgesellschaft 2006; MAY 24-27, 2006; Leipzig, Germany.
[Poster]
Wascher, TC; Dittrich, P; Sourij, H; Schmoelzer, I; Iglseder, B; Paulweber, B
Contribution of hypertension to early carotid atherosclerosis in subjects with and without the metabolic syndrome - An analysis of the SAPHIR-study
J HYPERTENSION. 24: S299-S299.
[Poster]
Web of Science
Stoschitzky, G; Stoschitzky, K; Wascher, TC
Long-term treatment with nebivolol does not cause nitrate tolerance
J MOL CELL CARDIOL 2005 38: 1070-1070.
Web of Science
Stoschitzky, G; Stoschitzky, K; Wascher, TC
Nicorandil does not cause nitrate tolerance when administered long-term
J MOL CELL CARDIOL 2005 38: 1070-1071.
Web of Science
Gug, A; Pilger, E; Peter, S; Paulweber, B; Bahadori, B; Schaflinger, E; Wascher, T
IL-6174G > C polymorphism association with carotid intima media thickness or manifest vascular disease?
ATHEROSCLER SUPPL 2004 5: 83-83.
Web of Science
Hoerzer, S; Wascher, TC; Lipp, RW; Haas, J; Klein, WW; Zweiker, R
Effects of oral magnesium (Mg++) and potassium (K+) therapy on thallium perfusion scan defects, quality of life and pulse wave analysis in hypertensive patients with syndrome X
AMER J HYPERTENS. 2004; 17: 71A-71A.-19th Annual Scientific Meeting of the American-Society-of-Hypertension; MAY 18-22, 2004; New York, NY.
[Poster]
Web of Science
Sourij, H; Stoschitzky, K; Klein, W; Roth, M; Dittrich, P; Wascher, TC
Prevalence of undiagnosed pathological glucose metabolism in patients undergoing elective coronary angiography
DIABETOLOGIA 2004 47: A127-A127.
Web of Science
Stoschitzky, G; Stoschitzky, K; Wascher, TC; Klein, W
Long-term therapy with nebivolol does not cause nitrate tolerance
J HYPERTENSION 2004 22: S251-S251.
Doi: 10.1097/00004872-200406002-00881
Web of Science
FullText
FullText_MUG
Wascher, TC; Schmolzer, I; Stuehlinger, M; Wiegratz, A; Enderle, M
Hyperglycemia-induced endothelial dysfunction in patients with impaired glucose tolerance is prevented by acarbose
EUR HEART J 2004 25: 512-512.
Web of Science
Renner, W; Schmolzer, I; Pressl, H; Paulweber, B; Wascher, TC
The human G-protein beta-3 subunit gene 825 C/T dimorphism is associated with Type 2 diabetes.
DIABETOLOGIA 2003 46: 365-365.
Web of Science
Schmoelzer, I; Renner, W; Paulweber, B; Iglseder, B; Wascher, TC
Different contribution of the C825T-polymorphism of GNB3 to the risk for advanced carotid atherosclerosis in individuals with and without metabolic syndrome.
DIABETOLOGIA 2002 45: 1175-1175.
Web of Science
Stuehlinger, MC; Kapoor, O; Schmoelzer, I; Graf, EE; Upson, BM; Oka, R; Szuba, A; Malinow, R; Stanger, O; Wascher, T; Pachinger, O; Cooke, JP
Effects of experimental hyperhomocysteinemia on elevation of plasma ADMA and endothelial dysfunction
CIRCULATION 2002 106: 213-213.
Web of Science
Wascher, TC; Boes, U
Different effects of glibenclamide and gliclazide on forearm vascular reserve in Type-2 diabetic patients.
DIABETOLOGIA 2002 45: 854-854.
Web of Science
Schmoelzer, I; Wascher, TC; Francesconi, M; Francesconi, C; Schmid, P; Schallmoser, K; Renner, W
Association of the Glu298Asp polymorphism of endothelial nitric oxide synthase with cardiovascular risk in type-II diabetes.
DIABETOLOGIA 2001 44: 1199-1199.
Web of Science
Wascher, TC; Schmoelzer, I; Paulweber, B; Malaimare, L; Stadlmayr, A; Iglseder, B; Renner, W
Association of a human G-protein beta 3 subunit polymorphism with reduced insulin sensitivity.
DIABETOLOGIA 2001 44: 364-364.
Web of Science
Boes, U; Klaus, E; Dittrich, P; Wascher, TC
Postprandial incrases of circulating methylglyoxal in type-II diabetic and non-diabetic subjects.
DIABETOLOGIA 1999 42: A327-A327.
Web of Science
Brunner, F; Russell, JC; Wslkart, G; Wascher, TC
Microvascular dysfunction and myocardial contractility in the JCR : LA-corpulent rat
CIRCULATION 1999 100: 554-554.
Web of Science
Wascher, TC; Wolkart, G; Brunner, F
Microvascular dysfunction and myocardial contractility in the JCR : LA-corpulent rat.
DIABETOLOGIA 1999 42: A77-A77.
Web of Science
Francesconi, M; Koizar, C; Wascher, TC
Acute hyperglycemia impairs resistance vessel function in insulin treated diabetics
DIABETOLOGIA 1998 41: A309-A309.
Web of Science
Koizar, C; Francesconi, M; Wascher, TC
Determinants of postischemic hyperemia in patients with diabetes mellitus
DIABETOLOGIA 1998 41: A311-A311.
Web of Science
Wascher, TC; Brunner, F
Contribution of vascular endothelial cells to the regulation of transcapillary insulin-transport
DIABETOLOGIA 1998 41: A174-A174.
Web of Science
Dimai, HP; Porta, S; Wimsberger, G; Wascher, T; WildersTruschnig, M; Leb, G; Lau, KHW
Evidence that oral magnesium (Mg) supplementation in young males suppresses bone turnover.
J BONE MINER RES 1997 12: F529-F529.
Web of Science
Wallner, S; Watzinger, N; Lindschinger, M; Wascher, TC; Toplak, H; Smolle, KH; Elmadfa, I; Eber, B; Klein, W; Krejs, GJ
Effects of intensified lifestyle modification on clinical restenosis after coronary angioplasty
ATHEROSCLEROSIS 1997 134: 268-268.
Doi: 10.1016/S0021-9150(97)89410-5
Web of Science
FullText
FullText_MUG
Wascher, TC; HabersackWallner, S; Bahadori, B; Roden, M; Novotny, P; Toplak, H
Effects of melatonin supplementation on plasma leptin levels.
DIABETOLOGIA 1997 40: 1064-1064.
Web of Science
Wascher, TC; Stollberger, R; Pammer, R; Wallner, S; Toplak, H
Forearm composition determines peak reactive hyperemia and flow debt repayment in healthy subjects
ATHEROSCLEROSIS 1997 134: 95-95.
Doi: 10.1016/S0021-9150(97)88548-6
Web of Science
FullText
FullText_MUG
Graier, WF; Simecek, S; Hoebel, HG; Wascher, TC; Kostner, GM
High-D-glucose-induced changes in endothelial Ca2+/EDRF signaling is due to generation of superoxide anions
DIABETOLOGIA 1996 39: 526-526.
Web of Science
HabersackWallner, S; Kreuz, E; Graier, WF; Bahadori, B; Toplak, H; Wascher, TC
Superoxide scavenging effects of free aminoacids
DIABETOLOGIA 1996 39: 855-855.
Web of Science
Wascher, TC; Graier, WF; Bahadori, B; Toplak, H
Effects of L-arginine on insulin-mediated vasodilation and insulin sensitivity in NIDDM and obesity.
DIABETOLOGIA 1996 39: 575-575.
Web of Science
GRAIER, WF; SIMECEK, S; WASCHER, TC; HOLZMANN, S; KUKOVETZ, WR; KOSTNER, GM
THE ALDOSE-REDUCTASE INHIBITOR, ZOPOLRESTAT, AMPLIFIES BLOOD-VESSEL RELAXATION BY INHIBITION OF CGMP-SPECIFIC PHOSPHODIESTERASE
DIABETOLOGIA 1995 38: A262-A262.
Web of Science
WASCHER, TC; GRAIER, WF; BAHADORI, B; TOPLAK, H
L-ARGININE IMPROVES INSULIN-RESISTANCE IN OBESE PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS
DIABETOLOGIA 1995 38: A158-A158.
Web of Science